ARCHIVES

DRCCA Bard Group Recommends No New Nationwide Screening Program Until More Research Is Done

This article is from The Cancer Letter archive.

Vol. 08 No. 43 | November 5, 1982

Download PDF Visit The Full Archive

Related Articles

Genetics Flexes Muscle At AACR Annual Meeting, Joint Session With ASCO On Genetic Charges

May 24, 1991

DCBD Board Like Organ Systems Program But Not RFAs, Okays Program Announcement, Contract Concepts

November 20, 1987

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

NCI Starts $2 Million Study On Cancer Patient Job Discrimination

January 17, 1975

DCCP Board Approves Concepts For Three New RFAs, Contract Recompetitions

June 4, 1982

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002